The tool reduces pathologist variability in liver biopsy assessment during trials of treatments for metabolic ...

EMA’s human medicines committee qualifies first AI tool to diagnose inflammatory liver disease in biopsy samples: Amsterdam, The Netherlands Saturday, March 22, 2025, 16:00 Hrs ...

AI-powered digital pathology specialist PathAI, based in Boston in the US, said that AIM-NASH AI Assist is designed to assist ...

Parasitic diseases are still the primary diseases that seriously threaten human health and life, and liver pathology is the leading cause of morbidity and ...

Gavreto is recommended as a first-line treatment for metastatic RET fusion-positive, metastatic non-small cell lung cancer, ...

Discover why Gyre Therapeutics is rated 'Hold' amid volatile stock behavior, uncertain long-term prospects, and pending Phase ...

Tribune raises EUR 37 million in seed and Series A funding to advance portfolio of therapies targeting central drivers of ...

CervoMed's stock soars 400% on promising dementia drug data. See more on insights, potential concerns, and what it means for ...

China: A new study published in the International Journal of General Medicine highlighted the potential role of serum cholinesterase (ChE) levels as a biomarker for assessing prognosis in ovarian ...

Programs address the need for disease-modifying therapies targeting root causes of fibrosis Funding will support advancement of CCN-family inhibitor TRX-44 into clinical trials for treatment ...

In 2021, liver disease led to 2.7 million emergency department (ED) visits in the U.S., 2 million hospitalizations, and ...

A deeper understanding of a gene that predisposes patients to fatty liver disease may open new avenues for treatment of the ...